Contribution of Common Genetic Variants to Risk of Early-Onset Ischemic Stroke

被引：6

作者：

Jaworek, Thomas ^{[1
]}

Xu, Huichun ^{[1
]}

Gaynor, Brady J. ^{[1
]}

Cole, John W. ^{[2
,6
]}

Rannikmae, Kristiina ^{[7
]}

Stanne, Tara M. ^{[8
]}

Tomppo, Liisa ^{[9
]}

Abedi, Vida ^{[10
]}

Amouyel, Philippe ^{[11
,12
,13
,14
]}

Armstrong, Nicole D. ^{[15
]}

Attia, John ^{[16
]}

Bell, Steven ^{[17
]}

Benavente, Oscar R. ^{[22
]}

Boncoraglio, Giorgio B. ^{[23
]}

Butterworth, Adam ^{[18
,19
,20
,21
,24
,25
]}

Carcel-Marquez, Jara ^{[26
]}

Chen, Zhengming ^{[27
]}

Chong, Michael ^{[29
,30
]}

Cruchaga, Carlos ^{[32
]}

Cushman, Mary ^{[35
]}

Danesh, John ^{[18
,19
,20
,21
,24
,25
,36
]}

Debette, Stephanie ^{[37
,38
]}

Duggan, David J. ^{[39
]}

Durda, Jon Peter ^{[33
,34
,40
]}

Engstrom, Gunnar ^{[41
]}

Enzinger, Chris ^{[43
]}

Faul, Jessica D. ^{[44
]}

Fecteau, Natalie S. ^{[2
]}

Fernandez-Cadenas, Israel ^{[26
,45
]}

Gieger, Christian ^{[46
,47
]}

Giese, Anne-Katrin ^{[48
]}

Grewal, Raji P. ^{[49
]}

Grittner, Ulrike ^{[50
]}

Havulinna, Aki S. ^{[51
]}

Heitsch, Laura ^{[52
,53
]}

Hochberg, Marc C. ^{[3
,4
]}

Holliday, Elizabeth ^{[16
]}

Hu, Jie ^{[57
]}

Ilinca, Andreea ^{[42
,58
]}

Irvin, Marguerite R. ^{[15
]}

Jackson, Rebecca D. ^{[59
]}

Jacob, Mina A. ^{[60
]}

Rabionet, Raquel ^{[61
,62
,63
]}

Jimenez-Conde, Jordi ^{[64
]}

Johnson, Julie A. ^{[65
,66
,67
]}

Kamatani, Yoichiro ^{[68
]}

Kardia, Sharon L. R. ^{[71
]}

Koido, Masaru

Kubo, Michiaki ^{[69
,70
,72
,73
]}

Lange, Leslie

机构：

[1] Univ Maryland, Sch Med, Div Endocrinol, Baltimore, MD 21201 USA

[2] Univ Maryland, Dept Neurol, Diabet & Nutr, Baltimore, MD 21201 USA

[3] Univ Maryland, Div Rheumatol & Clin Immunol, Baltimore, MD 21201 USA

[4] Univ Maryland, Dept Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA

[5] Univ Maryland, Inst Genome Sci, Baltimore, MD 21201 USA

[6] VA Maryland Hlth Care Syst, Baltimore, MD USA

[7] Univ Edinburgh, Usher Inst, Med Informat Ctr, Edinburgh, Midlothian, Scotland

[8] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Lab Med, Gothenburg, Sweden

[9] Helsinki Univ Hosp, Dept Neurol, Helsinki, Finland

[10] Geisinger Hlth Syst, Dept Mol & Funct Genom, Danville, PA USA

[11] Univ Lille, LabEx DISTALZ, RID AGE Risk Factors & Mol Determinants Aging Rel, U1167, Lille, France

[12] Inserm, U1167, Lille, France

[13] Ctr Hosp Univ Lille, Lille, France

[14] Inst Pasteur, Lille, France

[15] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA

[16] Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW, Australia

[17] Univ Cambridge, Stroke Res Grp, Cambridge, England

[18] Univ Cambridge, Dept Clin Neurosci, British Heart Fdn Cardiovasc Epidemiol Unit, Cambridge, England

[19] Univ Cambridge, Dept Publ Hlth & Primary Care, British Heart Fdn Ctr Res Excellence, Cambridge, England

[20] Univ Cambridge, Natl Inst Hlth Res, Blood & Transplant Res Unit Donor Hlth & Genom, Cambridge, England

[21] Univ Cambridge, Cambridge, England

[22] Univ British Columbia, Dept Neurol, Vancouver, BC, Canada

[23] Fdn IRCCS Ist Neurol Carlo Besta, Dept Cerebrovasc Dis, Milan, Italy

[24] Hlth Data Res UK Cambridge, Cambridge, England

[25] Wellcome Genome Campus, Cambridge, England

[26] Biomed Res Inst St Pau IIB St Pau, Stroke Pharmacogen & Genet Grp, Barcelona, Spain

[27] Univ Oxford, Nuffield Dept Populat Hlth, MRC Populat Hlth Res Unit, Oxford, England

[28] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford, England

[29] McMaster Univ, DBCVS Res Inst, Dept Pathol & Mol Med, Populat Hlth Res Inst, Hamilton, ON, Canada

[30] Thrombosis & Atherosclerosis Res Inst TaARI, Hamilton, ON, Canada

[31] Washington Univ, Sch Med, Dept Neurol, St Louis, MO USA

[32] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO USA

[33] Univ Vermont, Larner Coll Med, Dept Med, Burlington, VT USA

[34] Univ Vermont, Larner Coll Med, Lab Clin Biochem Res, Burlington, VT USA

[35] Univ Vermont, Larner Coll Med, Dept Med, Burlington, VT USA

[36] Wellcome Sanger Inst, Dept Human Genet, Hinxton, England

[37] Univ Bordeaux, Inserm Bordeux Populat Hlth Res Ctr, UMR 1219, Bordeaux, France

[38] Bordeaux Univ Hosp, Inst Neurodegenerat Dis, Dept Neurol, Bordeaux, France

[39] Affiliate City Hope, Translat Genom Res Inst, Quantitat Med & Syst Biol Div, Phoenix, AZ USA

[40] Lab Clin Biochem Res, Malmo, Sweden

[41] Dept Clin Sci, Malmo, Sweden

[42] Lund Univ, Dept Clin Sci, Neurol, Lund, Sweden

[43] Med Univ Graz, Dept Neurol, Graz, Austria

[44] Univ Michigan, Inst Social Res, Survey Res Ctr, Ann Arbor, MI USA

[45] Fundacio Docencia & Recerca MutuaTerrassa, Stroke Pharmacogen & Genet, Terrassa, Spain

[46] Helmholtz Zentrum Munchen German Res Ctr Environm, Unit Mol Epidemiol, Neuherberg, Germany

[47] Helmholtz Zentrum Munchen German Res Ctr Environm, Inst Epidemiol, Neuherberg, Germany

[48] Univ Klinikum Hamburg Eppendorf, Kopf & Neurozentrum, Klin & Poliklin Neurol, Hamburg, Germany

[49] St Francis Med Ctr, Neurosci Inst, Trenton, NJ USA

[50] Charite Univ Med Ctr, Dept Biostat & Clin Epidemiol, Berlin, Germany

来源：

NEUROLOGY | 2022年 / 99卷 / 16期

关键词：

ABO BLOOD-GROUP; GENOME-WIDE ASSOCIATION; CARDIOVASCULAR-DISEASE; LOCUS; GENOTYPE;

D O I：

10.1212/WNL.0000000000201006

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Background and Objectives Current genome-wide association studies of ischemic stroke have focused primarily on late-onset disease. As a complement to these studies, we sought to identify the contribution of common genetic variants to risk of early-onset ischemic stroke. Methods We performed a meta-analysis of genome-wide association studies of early-onset stroke (EOS), ages 18-59 years, using individual-level data or summary statistics in 16,730 cases and 599,237 nonstroke controls obtained across 48 different studies. We further compared effect sizes at associated loci between EOS and late-onset stroke (LOS) and compared polygenic risk scores (PRS) for venous thromboembolism (VTE) between EOS and LOS. Results We observed genome-wide significant associations of EOS with 2 variants in ABO, a known stroke locus. These variants tag blood subgroups O1 and A1, and the effect sizes of both variants were significantly larger in EOS compared with LOS. The odds ratio (OR) for rs529565, tagging O1, was 0.88 (95% confidence interval [CI]: 0.85-0.91) in EOS vs 0.96 (95% CI: 0.92-1.00) in LOS, and the OR for rs635634, tagging A1, was 1.16 (1.11-1.21) for EOS vs 1.05 (0.99-1.11) in LOS; p-values for interaction = 0.001 and 0.005, respectively. Using PRSs, we observed that greater genetic risk for VTE, another prothrombotic condition, was more strongly associated with EOS compared with LOS (p = 0.008). Discussion The ABO locus, genetically predicted blood group A, and higher genetic propensity for venous thrombosis are more strongly associated with EOS than with LOS, supporting a stronger role of prothrombotic factors in EOS.

引用

页码：E1738 / E1754

页数：17

共 50 条

[1] Contribution of rare and common genetic variants to early-onset type 2 diabetes
Pezzilli, S.
Tohidirad, M.
Biagini, T.
Alberico, F.
Mercuri, L.
Scarale, M. G.
Garofolo, M.
Mannino, G. C.
Filardi, T.
Andreozzi, F.
Mazza, T.
Prudente, S.
[J]. DIABETOLOGIA, 2020, 63 (SUPPL 1) : S170 - S170
[2] KIDNEY FUNCTION AND THE RISK FOR EARLY-ONSET ISCHEMIC STROKE
Kivioja, R.
Pietila, A.
Havulinna, A. S.
Salomaa, V.
Gordin, D.
Curtze, S.
Kaste, M.
Tatlisumak, T.
Putaala, J.
[J]. INTERNATIONAL JOURNAL OF STROKE, 2018, 13 : 79 - 79
[3] Sickle Cell Trait and Risk for Early-Onset Ischemic Stroke
Zhang, Rebecca
Ryan, Kathleen
Lopez, Haley
Flair, Zachary
Cole, John
Wozniak, Marcella
Phipps, Michael
Merino, Jose
Cronin, Carolyn
Kittner, Steven
[J]. NEUROLOGY, 2019, 92 (15)
[4] Common Genetic Variants and Early Onset Stroke Clues but No Answers
Majersik, Jennifer Juhl
Lacaze, Paul
[J]. NEUROLOGY, 2022, 99 (16) : 683 - 684
[5] SIGNIFICANT ASSOCIATIONS OF NRF1 GENETIC POLYMORPHISMS WITH THE RISK OF EARLY-ONSET ISCHEMIC STROKE
Huang, J. Y.
Chiou, H. Y.
Lien, L. M.
Jeng, J. S.
Lin, H. J.
Hu, C. J.
Hsieh, F. I.
[J]. ATHEROSCLEROSIS, 2019, 287 : E162 - E163
[6] Assessing the Cumulative Contribution of New and Established Common Genetic Risk Factors to Early-Onset Prostate Cancer
Lange, Ethan M.
Ribado, Jessica V.
Zuhlke, Kimberly A.
Johnson, Anna M.
Keele, Gregory R.
Li, Jin
Wang, Yunfei
Duan, Qing
Li, Ge
Gao, Zhengrong
Li, Yun
Xu, Jianfeng
Zheng, S. Lilly
Cooney, Kathleen A.
[J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2016, 25 (05) : 766 - 772
[7] Risk Factors for Early-Onset Ischemic Stroke: A Case-Control Study
Kivioja, Reetta
Pietila, Arto
Martinez-Majander, Nicolas
Gordin, Daniel
Havulinna, Aki S.
Salomaa, Veikko
Aarnio, Karoliina
Curtze, Sami
Leiviska, Jaana
Rodriguez-Pardo, Jorge
Surakka, Ida
Kaste, Markku
Tatlisumak, Turgut
Putaala, Jukka
[J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (21):
[8] Statin may reduce the risk of early-onset seizures after ischemic stroke
He, L.
Guo, J.
Chen, N.
Guo, J.
Fang, J. H.
[J]. CEREBROVASCULAR DISEASES, 2014, 37 : 657 - 657
[9] Asymmetric dimethylarginine as a risk marker for early-onset ischemic stroke in Indian population
Mamatha, Sopanahalli N.
Nagaraja, Dindagur
Philip, Mariamma
Christopher, Rita
[J]. CLINICA CHIMICA ACTA, 2011, 412 (1-2) : 139 - 142
[10] IMPACT OF SIRT6 AND SIRT7 GENETIC POLYMORPHISMS ON RISK OF EARLY-ONSET ISCHEMIC STROKE
Hsieh, F. I.
Huang, J. Y.
Chiou, H. Y.
Li-Ming, L.
Jeng, J. S.
Lin, H. J.
Hu, C. J.
[J]. ATHEROSCLEROSIS, 2019, 287 : E196 - E196

← 1 2 3 4 5 →